Reimbursement, Not Off-Label Use, May Be Hindering Carotid Stent Trials
Enrollment of randomized trials of carotid stents in low-risk patients has been slow because many doctors have an economic incentive to prevent their patients from being randomized, according to Kenneth Rosenfield, M.D., Massachusetts General Hospital
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
